United Drug posts 7% profit rise and looks to acquisitions

UPDATE: United Drug has posted a 7 per cent operating profit and its finance director Barry McGrane said that it may spend up to €200m on acquisitions in next 12 months.

9th May, 2012
United Drug finance director Barry McGrane with company chief executive Liam FitzGerald.

United Drug has posted a 7 per cent operating profit on 2 per cent revenue growth to €894 million, in its interim results for 2011.

A short time ago, the company's share price was down 0.9 per cent in Dublin, although Goodbody Stockbrokers maintained a Buy recommendation on the stock saying: "we are encouraged by the earnings progression."

“It is a return to good earnings growth,” United Drug finance director Barry McGrane told the *Daily Business Post* this morning....

Subscribe from just €1 for the first month!


What's Included

With any subscription you will have access to

  • 971569B3-2C5E-4C45-B798-CEADE16987A8

    Unlimited multi-device access to our iPad, iPhone and Android Apps

  • 099C8662-C57C-42F2-9426-F2F90DF17C8F

    Unlimited access to our eReader library

  • 198AE43B-B9CF-4892-8769-D63C2104BA08

    Exclusive daily insight and opinion seven days a week

  • D8F37B78-25E4-4E4A-A376-4F5789B1564A

    Create alerts to never miss a subject that matters to you

  • B15F2521-37CD-4E02-B898-730A20D39F7F

    Get access to exclusive offers for subscribers on gifts and experiences

  • A564FE02-1AB8-4579-AF9D-BA32A2E5ACA7

    Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine

Share this post

Related Stories

The year in review

Legacy Richie Oakley 1 year ago

Newsround: What Thursday’s papers say

Legacy Leanna Byrne 5 years ago

More cycle routes, expansion of Luas to Bray and new bus network proposed

Legacy Digital Desk 5 years ago